ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,178,000 | +35.9% | 12,654 | -0.9% | 0.02% | +22.2% |
Q2 2021 | $1,603,000 | -7.4% | 12,772 | +0.1% | 0.02% | -18.2% |
Q1 2021 | $1,731,000 | +4.2% | 12,763 | -1.8% | 0.02% | +15.8% |
Q4 2020 | $1,661,000 | -99.9% | 12,994 | +1.6% | 0.02% | -29.6% |
Q3 2020 | $1,440,000,000 | – | 12,794 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
RA Capital Management | 318,565 | $11,529,000 | 1.19% |
OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
QVT Financial LP | 636,764 | $23,044,000 | 0.87% |